Dermatology
Conference Coverage
IL-23 inhibitor topped ustekinumab against psoriasis
Key clinical point: The interleukin-23 inhibitor BI 655066 outperformed ustekinumab and generated no concerning safety signals in a small phase II...
News
Personalized melanoma vaccine evokes immune response
Key clinical point: Vaccination against patient-specific tumor neoantigens may represent a novel therapeutic strategy in melanoma and other...
News
No increased risk of lung disease with methotrexate
Key clinical point: Methotrexate is not associated with an increased risk of pulmonary disease. Major finding: There was no increased risk of...
Conference Coverage
Weekly adalimumab at 40 mg works best for hidradenitis suppurativa
Key clinical point: Weekly treatment with 40 mg adalimumab was the best medium-term dose for hidradenitis suppurativa.
Video
VIDEO: PDT tops blue-light therapy for actinic keratosis
Conference Coverage
VIDEO: Sun protection urged for Asian, Hispanic women
Video
VIDEO: How to use spironolactone safely for acne
Video
VIDEO: Ask vitiligo patients about autoimmune symptoms
News
Methotrexate and biologics linked to higher zoster risk in psoriasis
Key clinical point: The combination of methotrexate and biologics for the treatment of psoriasis may increase the risk of herpes zoster infection...
News
No increased rate of hyperkalemia in healthy women taking spironolactone for acne
Key clinical point: Young women taking spironolactone for hormonally mediated acne do not show an increased risk of hyperkalemia. Major finding:...
News
Dupilumab improves moderate to severe atopic dermatitis in adults
Key clinical point: Dupilumab met its safety endpoints and significantly outperformed placebo on several clinical measures for adults with...